The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells
Open accessAbstract
We have previously shown that multidrug-resistant cancer cells display elevated levels of glucosylceramide (Lavie, Y., Cao, H., Bursten, S. L., Giuliano, A. E., and Cabot, M. C. (1996) J. Biol. Chem. 271, 19530-19536). In this study we used the multidrug-resistant human breast cancer cell line MCF-7-Adriamycin-resistant (AdrR), which exhibits marked accumulation of glucosylceramide compared with the parental MCF-7 wild type (drug-sensitive) cell line, to define the relationship between glycolipids and multidrug resistance (MDR). Herein it is shown that clinically relevant concentrations of tamoxifen, verapamil, and cyclosporin A, all circumventors of MDR, markedly decrease glucosylceramide levels in MCF-7-AdrR cells (IC50 values, 1. 0, 0.8, and 2.3 microM, respectively). In intact cells, tamoxifen inhibited glycosphingolipid synthesis at the step of ceramide glycosylation. In cell-free assays for glucosylceramide synthase, tamoxifen (1:10 molar ratio with ceramide) inhibited glucosylceramide formation by nearly 50%. In cell cultures, inhibition of glucosylceramide synthesis by tamoxifen is correlated with its ability to sensitize MCF-7-AdrR cells to Adriamycin toxicity. Moreover, treatment of cells with 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, likewise sensitized MCF-7-AdrR cells to Adriamycin. It is concluded that high cellular levels of glucosylceramide are correlated with MDR, and that glycolipids are a target for the action of MDR-reversing agents such as tamoxifen. The data entertain the notion that drug resistance phenomena are aligned with cell capacity to metabolize ceramide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular Regulation
Hannun, Y. A., & Bell, R. M. (1989) · Science · doi:10.1126/science.2643164 · Cited by 1,251
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Yusa, K., & TSURUO, T. (1989) · PubMed · Cited by 365
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Self-citationCyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
Slater, L. M., Sweet, P., Stupecky, M., & Gupta, S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112450 · Cited by 316
Nilsson, O., & Svennerholm, L. T. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07950.x · Cited by 283
P-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
The effects of lipids and detergents on ATPase-active P-glycoprotein
Doige, C. A., Yu, X., & Sharom, F. J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90339-2 · Cited by 188
Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons
Harel, R., & Futerman, A. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85263-8 · Cited by 183
Blobe, G. C., Sachs, C. W., Khan, W. A., Fabbro, D., Stabel, S., Wetsel, W. C., Obeid, L. M., Fine, R. L., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54202-2 · Cited by 165
A Regulatory Role for Sphingolipids in Neuronal Growth
Schwarz, A., Rapaport, E., Hirschberg, K., & Futerman, A. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10990 · Cited by 161
Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide Synthase
Rani, S. C. S., Abe, A., Chang, Y., Rosenzweig, N., Saltiel, A. R., Radin, N. S., & Shayman, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2859 · Cited by 159
Abe, A., Radin, N. S., Shayman, J. A., Wotring, L. L., Zipkin, R. E., Sivakumar, R., Ruggieri, J. M., Carson, K. G., & Ganem, B. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39895-3 · Cited by 148
Interaction of tamoxifen with the multidrug resistance P-glycoprotein
Callaghan, R., & Higgins, C. F. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.59 · Cited by 115
Watanabe, T., Tsuge, H., Oh‐hara, T., Naito, M., & Tsuruo, T. (1995) · Acta Oncologica · doi:10.3109/02841869509093961 · Cited by 103
Sachs, C. W., Safa, A. R., Harrison, S. D., & Fine, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26639 · Cited by 99
A Novel Enzyme That Catalyzes the Esterification of -Acetylsphingosine
Abe, A., Shayman, J. A., & Radin, N. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14383 · Cited by 92
GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression
Thurin, J., Thurin, M., Herlyn, M., Elder, D. E., Steplewski, Z., Clark, W. H., & Koprowski, H. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81522-8 · Cited by 85
Nakamura, S., Kozutsumi, Y., Sun, Y., Miyake, Y., Fujita, T., & Kawasaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1255 · Cited by 75
May, G. L., Wright, L. C., Dyne, M., Mackinnon, W. B., Fox, R. M., & Mountford, C. E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420517 · Cited by 72
Glucosylceramides stimulate murine epidermal hyperproliferation.
Marsh, N. L., Elias, P. M., & Holleran, W. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117997 · Cited by 70
Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance
Jaffrézou, J., Chen, K. G., Durán, G. E., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)00219-5 · Cited by 56
Yan, J., Ilsley, D. D., Frohlick, C., Steet, R., Hall, E. T., Kuchta, R. D., & ̧on, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22836 · Cited by 55
Kirk, J., Syed, S. K., Harris, A. L., Jarman, M., Roufogalis, B. D., Stratford, I. J., & Carmichael, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90098-1 · Cited by 46
Chapter 19 Tumor gangliosides as targets for active specific immunotherapy of melanoma in man
Morton, D. L., Ravindranath, M. H., & Irie, R. F. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61954-8 · Cited by 39
Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells.
Rosenwald, A., & Pagano, R. E. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39966-1 · Cited by 26
Tamoxifen elicits rapid transmembrane lipid signal responses in human breast cancer cells
Cabot, M. C., Zhang, Z.-C., & Giuliano, A. E. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00713401 · Cited by 19
Self-citation
Cited by
Zheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 560
Self-citationEnzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling
Hannun, Y. A., Luberto, C., & Argraves, K. M. (2001) · Biochemistry · doi:10.1021/bi002836k · Cited by 500
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Mechanisms of tamoxifen-induced apoptosis
Mandlekar, S., & Kong, A.-N. T. (2001) · Apoptosis · doi:10.1023/a:1012437607881 · Cited by 394
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Metadata
- Authors
- Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A. E., & Cabot, M. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 272
- Issue
- 3
- Pages
- 1682-1687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2090980124
- Cited by
- 284
- References
- 31
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.